Pituitary apoplexy after leuprolide administration for carcinoma of the prostate: what's new?
Faustini-Fustini
M
M
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D008297:Male; D010899:Pituitary Apoplexy / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy
D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide